nodes	percent_of_prediction	percent_of_DWPC	metapath
Alprostadil—PTGIR—pulmonary artery—sarcoma	0.0589	0.161	CbGeAlD
Alprostadil—PTGIR—endothelium—sarcoma	0.0184	0.0504	CbGeAlD
Alprostadil—PTGER2—myometrium—sarcoma	0.018	0.0492	CbGeAlD
Alprostadil—ABCC5—mammary gland—sarcoma	0.0119	0.0324	CbGeAlD
Alprostadil—PTGER2—uterus—sarcoma	0.0117	0.0319	CbGeAlD
Alprostadil—PTGER2—tendon—sarcoma	0.0102	0.0279	CbGeAlD
Alprostadil—PTGER2—bone marrow—sarcoma	0.00992	0.0271	CbGeAlD
Alprostadil—SLCO3A1—myometrium—sarcoma	0.00931	0.0254	CbGeAlD
Alprostadil—SLCO2B1—mammary gland—sarcoma	0.0093	0.0254	CbGeAlD
Alprostadil—SLCO2A1—myometrium—sarcoma	0.00922	0.0252	CbGeAlD
Alprostadil—PTGIR—hematopoietic system—sarcoma	0.00906	0.0247	CbGeAlD
Alprostadil—PTGIR—connective tissue—sarcoma	0.00872	0.0238	CbGeAlD
Alprostadil—PTGER2—testis—sarcoma	0.00848	0.0231	CbGeAlD
Alprostadil—SLCO3A1—seminal vesicle—sarcoma	0.00841	0.023	CbGeAlD
Alprostadil—SLCO2A1—seminal vesicle—sarcoma	0.00833	0.0227	CbGeAlD
Alprostadil—PTGIR—smooth muscle tissue—sarcoma	0.00798	0.0218	CbGeAlD
Alprostadil—SLCO2A1—skin of body—sarcoma	0.00688	0.0188	CbGeAlD
Alprostadil—PTGER2—lymph node—sarcoma	0.00614	0.0168	CbGeAlD
Alprostadil—SLCO3A1—cardiac atrium—sarcoma	0.00607	0.0166	CbGeAlD
Alprostadil—SLCO2A1—cardiac atrium—sarcoma	0.00601	0.0164	CbGeAlD
Alprostadil—SLCO2A1—uterus—sarcoma	0.00598	0.0163	CbGeAlD
Alprostadil—SLCO2B1—hematopoietic system—sarcoma	0.00567	0.0155	CbGeAlD
Alprostadil—ABCC5—cardiac atrium—sarcoma	0.0055	0.015	CbGeAlD
Alprostadil—SLCO3A1—tendon—sarcoma	0.00529	0.0144	CbGeAlD
Alprostadil—SLCO2A1—tendon—sarcoma	0.00524	0.0143	CbGeAlD
Alprostadil—ABCC4—hematopoietic system—sarcoma	0.00502	0.0137	CbGeAlD
Alprostadil—PTGIR—testis—sarcoma	0.00496	0.0136	CbGeAlD
Alprostadil—ABCC5—tendon—sarcoma	0.00479	0.0131	CbGeAlD
Alprostadil—PTGIR—liver—sarcoma	0.00469	0.0128	CbGeAlD
Alprostadil—ABCC5—bone marrow—sarcoma	0.00464	0.0127	CbGeAlD
Alprostadil—SLCO3A1—testis—sarcoma	0.00438	0.012	CbGeAlD
Alprostadil—SLCO2A1—testis—sarcoma	0.00434	0.0118	CbGeAlD
Alprostadil—SLCO2B1—uterus—sarcoma	0.00428	0.0117	CbGeAlD
Alprostadil—SLCO3A1—liver—sarcoma	0.00414	0.0113	CbGeAlD
Alprostadil—SLCO2A1—liver—sarcoma	0.0041	0.0112	CbGeAlD
Alprostadil—ABCC5—testis—sarcoma	0.00397	0.0108	CbGeAlD
Alprostadil—ABCC4—uterus—sarcoma	0.00379	0.0104	CbGeAlD
Alprostadil—ABCC5—liver—sarcoma	0.00375	0.0102	CbGeAlD
Alprostadil—SLCO2B1—tendon—sarcoma	0.00375	0.0102	CbGeAlD
Alprostadil—PTGIR—lymph node—sarcoma	0.0036	0.00982	CbGeAlD
Alprostadil—ABCC4—tendon—sarcoma	0.00332	0.00907	CbGeAlD
Alprostadil—ABCC4—bone marrow—sarcoma	0.00322	0.00878	CbGeAlD
Alprostadil—SLCO3A1—lymph node—sarcoma	0.00318	0.00867	CbGeAlD
Alprostadil—SLCO2A1—lymph node—sarcoma	0.00315	0.00859	CbGeAlD
Alprostadil—SLCO2B1—testis—sarcoma	0.00311	0.00848	CbGeAlD
Alprostadil—SLCO2B1—liver—sarcoma	0.00294	0.00802	CbGeAlD
Alprostadil—ABCC5—lymph node—sarcoma	0.00288	0.00785	CbGeAlD
Alprostadil—ABCC4—testis—sarcoma	0.00275	0.00751	CbGeAlD
Alprostadil—ABCC4—liver—sarcoma	0.0026	0.0071	CbGeAlD
Alprostadil—SLCO2B1—lymph node—sarcoma	0.00225	0.00615	CbGeAlD
Alprostadil—ABCC4—lymph node—sarcoma	0.00199	0.00544	CbGeAlD
Alprostadil—Haemorrhage—Mitoxantrone—sarcoma	0.00183	0.00289	CcSEcCtD
Alprostadil—Pharyngitis—Mitoxantrone—sarcoma	0.00182	0.00287	CcSEcCtD
Alprostadil—Nervousness—Thiotepa—sarcoma	0.0018	0.00283	CcSEcCtD
Alprostadil—Vasodilation procedure—Doxorubicin—sarcoma	0.00179	0.00283	CcSEcCtD
Alprostadil—Vasodilation—Doxorubicin—sarcoma	0.00179	0.00283	CcSEcCtD
Alprostadil—Back pain—Thiotepa—sarcoma	0.00179	0.00282	CcSEcCtD
Alprostadil—Hyperbilirubinaemia—Doxorubicin—sarcoma	0.00173	0.00273	CcSEcCtD
Alprostadil—Anaemia—Thiotepa—sarcoma	0.00171	0.0027	CcSEcCtD
Alprostadil—Anaemia—Dactinomycin—sarcoma	0.0017	0.00268	CcSEcCtD
Alprostadil—Injection site reaction—Epirubicin—sarcoma	0.00169	0.00267	CcSEcCtD
Alprostadil—Acute coronary syndrome—Etoposide—sarcoma	0.00167	0.00264	CcSEcCtD
Alprostadil—Hyperkalaemia—Epirubicin—sarcoma	0.00167	0.00264	CcSEcCtD
Alprostadil—Renal failure—Etoposide—sarcoma	0.00167	0.00264	CcSEcCtD
Alprostadil—Myocardial infarction—Etoposide—sarcoma	0.00167	0.00263	CcSEcCtD
Alprostadil—Influenza like illness—Epirubicin—sarcoma	0.00165	0.00261	CcSEcCtD
Alprostadil—Cough—Thiotepa—sarcoma	0.00161	0.00255	CcSEcCtD
Alprostadil—Convulsion—Thiotepa—sarcoma	0.0016	0.00253	CcSEcCtD
Alprostadil—Erythema—Mitoxantrone—sarcoma	0.0016	0.00252	CcSEcCtD
Alprostadil—Hypertension—Thiotepa—sarcoma	0.0016	0.00252	CcSEcCtD
Alprostadil—Back pain—Vincristine—sarcoma	0.00159	0.0025	CcSEcCtD
Alprostadil—Injection site reaction—Doxorubicin—sarcoma	0.00157	0.00247	CcSEcCtD
Alprostadil—Cramps of lower extremities—Epirubicin—sarcoma	0.00156	0.00247	CcSEcCtD
Alprostadil—Hyperkalaemia—Doxorubicin—sarcoma	0.00155	0.00244	CcSEcCtD
Alprostadil—Back pain—Mitoxantrone—sarcoma	0.00154	0.00244	CcSEcCtD
Alprostadil—Discomfort—Dactinomycin—sarcoma	0.00154	0.00244	CcSEcCtD
Alprostadil—Ecchymosis—Epirubicin—sarcoma	0.00154	0.00243	CcSEcCtD
Alprostadil—Influenza like illness—Doxorubicin—sarcoma	0.00153	0.00241	CcSEcCtD
Alprostadil—Hypoaesthesia—Etoposide—sarcoma	0.00152	0.00239	CcSEcCtD
Alprostadil—Anaemia—Vincristine—sarcoma	0.00151	0.00239	CcSEcCtD
Alprostadil—Infection—Thiotepa—sarcoma	0.0015	0.00237	CcSEcCtD
Alprostadil—Oedema—Dactinomycin—sarcoma	0.0015	0.00236	CcSEcCtD
Alprostadil—Urethral disorder—Etoposide—sarcoma	0.0015	0.00236	CcSEcCtD
Alprostadil—Infection—Dactinomycin—sarcoma	0.00149	0.00235	CcSEcCtD
Alprostadil—Abnormal vision—Epirubicin—sarcoma	0.00148	0.00234	CcSEcCtD
Alprostadil—Sepsis—Epirubicin—sarcoma	0.00148	0.00233	CcSEcCtD
Alprostadil—Thrombocytopenia—Thiotepa—sarcoma	0.00148	0.00233	CcSEcCtD
Alprostadil—Anaemia—Mitoxantrone—sarcoma	0.00148	0.00233	CcSEcCtD
Alprostadil—Tachycardia—Thiotepa—sarcoma	0.00147	0.00232	CcSEcCtD
Alprostadil—Thrombocytopenia—Dactinomycin—sarcoma	0.00147	0.00231	CcSEcCtD
Alprostadil—Skin disorder—Thiotepa—sarcoma	0.00147	0.00231	CcSEcCtD
Alprostadil—Cramps of lower extremities—Doxorubicin—sarcoma	0.00145	0.00228	CcSEcCtD
Alprostadil—Ecchymosis—Doxorubicin—sarcoma	0.00142	0.00225	CcSEcCtD
Alprostadil—Diabetes mellitus—Epirubicin—sarcoma	0.00142	0.00224	CcSEcCtD
Alprostadil—Convulsion—Vincristine—sarcoma	0.00142	0.00224	CcSEcCtD
Alprostadil—Flushing—Etoposide—sarcoma	0.00142	0.00223	CcSEcCtD
Alprostadil—Hypertension—Vincristine—sarcoma	0.00142	0.00223	CcSEcCtD
Alprostadil—Cough—Mitoxantrone—sarcoma	0.00139	0.0022	CcSEcCtD
Alprostadil—Convulsion—Mitoxantrone—sarcoma	0.00138	0.00218	CcSEcCtD
Alprostadil—Hypertension—Mitoxantrone—sarcoma	0.00138	0.00217	CcSEcCtD
Alprostadil—Abnormal vision—Doxorubicin—sarcoma	0.00137	0.00217	CcSEcCtD
Alprostadil—Sepsis—Doxorubicin—sarcoma	0.00137	0.00216	CcSEcCtD
Alprostadil—Cardiac failure congestive—Epirubicin—sarcoma	0.00136	0.00215	CcSEcCtD
Alprostadil—Discomfort—Mitoxantrone—sarcoma	0.00134	0.00212	CcSEcCtD
Alprostadil—Oedema—Vincristine—sarcoma	0.00134	0.00211	CcSEcCtD
Alprostadil—Infection—Vincristine—sarcoma	0.00133	0.0021	CcSEcCtD
Alprostadil—Dyspepsia—Thiotepa—sarcoma	0.00133	0.0021	CcSEcCtD
Alprostadil—Diabetes mellitus—Doxorubicin—sarcoma	0.00131	0.00207	CcSEcCtD
Alprostadil—Thrombocytopenia—Vincristine—sarcoma	0.00131	0.00207	CcSEcCtD
Alprostadil—Oedema—Mitoxantrone—sarcoma	0.0013	0.00206	CcSEcCtD
Alprostadil—Infection—Mitoxantrone—sarcoma	0.00129	0.00204	CcSEcCtD
Alprostadil—Hyperhidrosis—Vincristine—sarcoma	0.00129	0.00204	CcSEcCtD
Alprostadil—Pain—Thiotepa—sarcoma	0.00129	0.00204	CcSEcCtD
Alprostadil—Back pain—Etoposide—sarcoma	0.00128	0.00203	CcSEcCtD
Alprostadil—Shock—Mitoxantrone—sarcoma	0.00128	0.00202	CcSEcCtD
Alprostadil—Pain—Dactinomycin—sarcoma	0.00128	0.00202	CcSEcCtD
Alprostadil—Muscle spasms—Etoposide—sarcoma	0.00128	0.00201	CcSEcCtD
Alprostadil—Thrombocytopenia—Mitoxantrone—sarcoma	0.00128	0.00201	CcSEcCtD
Alprostadil—Tachycardia—Mitoxantrone—sarcoma	0.00127	0.00201	CcSEcCtD
Alprostadil—Hypoglycaemia—Epirubicin—sarcoma	0.00127	0.002	CcSEcCtD
Alprostadil—Skin disorder—Mitoxantrone—sarcoma	0.00127	0.002	CcSEcCtD
Alprostadil—Lethargy—Epirubicin—sarcoma	0.00126	0.00199	CcSEcCtD
Alprostadil—Cardiac failure congestive—Doxorubicin—sarcoma	0.00126	0.00199	CcSEcCtD
Alprostadil—Hyperhidrosis—Mitoxantrone—sarcoma	0.00126	0.00199	CcSEcCtD
Alprostadil—Hypotension—Vincristine—sarcoma	0.00125	0.00197	CcSEcCtD
Alprostadil—Feeling abnormal—Thiotepa—sarcoma	0.00124	0.00196	CcSEcCtD
Alprostadil—Pain in extremity—Epirubicin—sarcoma	0.00124	0.00195	CcSEcCtD
Alprostadil—Feeling abnormal—Dactinomycin—sarcoma	0.00123	0.00195	CcSEcCtD
Alprostadil—Anaemia—Etoposide—sarcoma	0.00123	0.00194	CcSEcCtD
Alprostadil—Hypotension—Mitoxantrone—sarcoma	0.00122	0.00192	CcSEcCtD
Alprostadil—Body temperature increased—Thiotepa—sarcoma	0.00119	0.00188	CcSEcCtD
Alprostadil—Abdominal pain—Thiotepa—sarcoma	0.00119	0.00188	CcSEcCtD
Alprostadil—Body temperature increased—Dactinomycin—sarcoma	0.00118	0.00187	CcSEcCtD
Alprostadil—Abdominal pain—Dactinomycin—sarcoma	0.00118	0.00187	CcSEcCtD
Alprostadil—Cardiac arrest—Epirubicin—sarcoma	0.00118	0.00185	CcSEcCtD
Alprostadil—Hypoglycaemia—Doxorubicin—sarcoma	0.00117	0.00185	CcSEcCtD
Alprostadil—Loss of consciousness—Etoposide—sarcoma	0.00117	0.00184	CcSEcCtD
Alprostadil—Lethargy—Doxorubicin—sarcoma	0.00117	0.00184	CcSEcCtD
Alprostadil—Cough—Etoposide—sarcoma	0.00116	0.00183	CcSEcCtD
Alprostadil—Blood creatinine increased—Epirubicin—sarcoma	0.00116	0.00183	CcSEcCtD
Alprostadil—Convulsion—Etoposide—sarcoma	0.00115	0.00182	CcSEcCtD
Alprostadil—Dyspepsia—Mitoxantrone—sarcoma	0.00115	0.00181	CcSEcCtD
Alprostadil—Hypertension—Etoposide—sarcoma	0.00115	0.00181	CcSEcCtD
Alprostadil—Pain—Vincristine—sarcoma	0.00114	0.00181	CcSEcCtD
Alprostadil—Pain in extremity—Doxorubicin—sarcoma	0.00114	0.0018	CcSEcCtD
Alprostadil—Hypokalaemia—Epirubicin—sarcoma	0.00112	0.00177	CcSEcCtD
Alprostadil—Discomfort—Etoposide—sarcoma	0.00112	0.00176	CcSEcCtD
Alprostadil—Pain—Mitoxantrone—sarcoma	0.00111	0.00176	CcSEcCtD
Alprostadil—Cardiac arrest—Doxorubicin—sarcoma	0.00109	0.00172	CcSEcCtD
Alprostadil—Asthenia—Thiotepa—sarcoma	0.00108	0.00171	CcSEcCtD
Alprostadil—Infection—Etoposide—sarcoma	0.00108	0.0017	CcSEcCtD
Alprostadil—Asthenia—Dactinomycin—sarcoma	0.00107	0.0017	CcSEcCtD
Alprostadil—Feeling abnormal—Mitoxantrone—sarcoma	0.00107	0.00169	CcSEcCtD
Alprostadil—Blood creatinine increased—Doxorubicin—sarcoma	0.00107	0.00169	CcSEcCtD
Alprostadil—Influenza—Epirubicin—sarcoma	0.00107	0.00169	CcSEcCtD
Alprostadil—Pruritus—Thiotepa—sarcoma	0.00107	0.00168	CcSEcCtD
Alprostadil—Thrombocytopenia—Etoposide—sarcoma	0.00106	0.00167	CcSEcCtD
Alprostadil—Tachycardia—Etoposide—sarcoma	0.00106	0.00167	CcSEcCtD
Alprostadil—Body temperature increased—Vincristine—sarcoma	0.00106	0.00167	CcSEcCtD
Alprostadil—Abdominal pain—Vincristine—sarcoma	0.00106	0.00167	CcSEcCtD
Alprostadil—Skin disorder—Etoposide—sarcoma	0.00105	0.00166	CcSEcCtD
Alprostadil—Hyperhidrosis—Etoposide—sarcoma	0.00105	0.00165	CcSEcCtD
Alprostadil—Hypokalaemia—Doxorubicin—sarcoma	0.00104	0.00164	CcSEcCtD
Alprostadil—Diarrhoea—Thiotepa—sarcoma	0.00103	0.00163	CcSEcCtD
Alprostadil—Abdominal pain—Mitoxantrone—sarcoma	0.00103	0.00163	CcSEcCtD
Alprostadil—Body temperature increased—Mitoxantrone—sarcoma	0.00103	0.00163	CcSEcCtD
Alprostadil—Bronchitis—Epirubicin—sarcoma	0.00103	0.00162	CcSEcCtD
Alprostadil—Diarrhoea—Dactinomycin—sarcoma	0.00102	0.00162	CcSEcCtD
Alprostadil—Hypotension—Etoposide—sarcoma	0.00101	0.0016	CcSEcCtD
Alprostadil—Dizziness—Thiotepa—sarcoma	0.000998	0.00157	CcSEcCtD
Alprostadil—Upper respiratory tract infection—Epirubicin—sarcoma	0.000993	0.00157	CcSEcCtD
Alprostadil—Influenza—Doxorubicin—sarcoma	0.000988	0.00156	CcSEcCtD
Alprostadil—Pollakiuria—Epirubicin—sarcoma	0.000987	0.00156	CcSEcCtD
Alprostadil—Hyperglycaemia—Epirubicin—sarcoma	0.000964	0.00152	CcSEcCtD
Alprostadil—Asthenia—Vincristine—sarcoma	0.00096	0.00151	CcSEcCtD
Alprostadil—Rash—Thiotepa—sarcoma	0.000951	0.0015	CcSEcCtD
Alprostadil—Bronchitis—Doxorubicin—sarcoma	0.000951	0.0015	CcSEcCtD
Alprostadil—Dermatitis—Thiotepa—sarcoma	0.00095	0.0015	CcSEcCtD
Alprostadil—Headache—Thiotepa—sarcoma	0.000945	0.00149	CcSEcCtD
Alprostadil—Rash—Dactinomycin—sarcoma	0.000944	0.00149	CcSEcCtD
Alprostadil—Renal failure—Epirubicin—sarcoma	0.000936	0.00148	CcSEcCtD
Alprostadil—Asthenia—Mitoxantrone—sarcoma	0.000935	0.00148	CcSEcCtD
Alprostadil—Pain—Etoposide—sarcoma	0.000927	0.00146	CcSEcCtD
Alprostadil—Urinary tract infection—Epirubicin—sarcoma	0.000926	0.00146	CcSEcCtD
Alprostadil—Upper respiratory tract infection—Doxorubicin—sarcoma	0.000919	0.00145	CcSEcCtD
Alprostadil—Diarrhoea—Vincristine—sarcoma	0.000915	0.00144	CcSEcCtD
Alprostadil—Pollakiuria—Doxorubicin—sarcoma	0.000913	0.00144	CcSEcCtD
Alprostadil—Haematuria—Epirubicin—sarcoma	0.000908	0.00143	CcSEcCtD
Alprostadil—Nausea—Thiotepa—sarcoma	0.000896	0.00141	CcSEcCtD
Alprostadil—Sinusitis—Epirubicin—sarcoma	0.000894	0.00141	CcSEcCtD
Alprostadil—Feeling abnormal—Etoposide—sarcoma	0.000893	0.00141	CcSEcCtD
Alprostadil—Hyperglycaemia—Doxorubicin—sarcoma	0.000892	0.00141	CcSEcCtD
Alprostadil—Diarrhoea—Mitoxantrone—sarcoma	0.000891	0.00141	CcSEcCtD
Alprostadil—Nausea—Dactinomycin—sarcoma	0.000889	0.0014	CcSEcCtD
Alprostadil—Dizziness—Vincristine—sarcoma	0.000885	0.0014	CcSEcCtD
Alprostadil—Bradycardia—Epirubicin—sarcoma	0.00087	0.00137	CcSEcCtD
Alprostadil—Renal failure—Doxorubicin—sarcoma	0.000866	0.00137	CcSEcCtD
Alprostadil—Haemoglobin—Epirubicin—sarcoma	0.000859	0.00136	CcSEcCtD
Alprostadil—Rhinitis—Epirubicin—sarcoma	0.000857	0.00135	CcSEcCtD
Alprostadil—Abdominal pain—Etoposide—sarcoma	0.000857	0.00135	CcSEcCtD
Alprostadil—Body temperature increased—Etoposide—sarcoma	0.000857	0.00135	CcSEcCtD
Alprostadil—Urinary tract infection—Doxorubicin—sarcoma	0.000857	0.00135	CcSEcCtD
Alprostadil—Haemorrhage—Epirubicin—sarcoma	0.000855	0.00135	CcSEcCtD
Alprostadil—Hypoaesthesia—Epirubicin—sarcoma	0.000851	0.00134	CcSEcCtD
Alprostadil—Pharyngitis—Epirubicin—sarcoma	0.000849	0.00134	CcSEcCtD
Alprostadil—Rash—Vincristine—sarcoma	0.000843	0.00133	CcSEcCtD
Alprostadil—Dermatitis—Vincristine—sarcoma	0.000843	0.00133	CcSEcCtD
Alprostadil—Haematuria—Doxorubicin—sarcoma	0.00084	0.00133	CcSEcCtD
Alprostadil—Urethral disorder—Epirubicin—sarcoma	0.000838	0.00132	CcSEcCtD
Alprostadil—Headache—Vincristine—sarcoma	0.000838	0.00132	CcSEcCtD
Alprostadil—Sinusitis—Doxorubicin—sarcoma	0.000827	0.0013	CcSEcCtD
Alprostadil—Visual impairment—Epirubicin—sarcoma	0.000824	0.0013	CcSEcCtD
Alprostadil—Rash—Mitoxantrone—sarcoma	0.000821	0.0013	CcSEcCtD
Alprostadil—Dermatitis—Mitoxantrone—sarcoma	0.000821	0.0013	CcSEcCtD
Alprostadil—Headache—Mitoxantrone—sarcoma	0.000816	0.00129	CcSEcCtD
Alprostadil—Bradycardia—Doxorubicin—sarcoma	0.000805	0.00127	CcSEcCtD
Alprostadil—Haemoglobin—Doxorubicin—sarcoma	0.000795	0.00125	CcSEcCtD
Alprostadil—Nausea—Vincristine—sarcoma	0.000795	0.00125	CcSEcCtD
Alprostadil—Flushing—Epirubicin—sarcoma	0.000794	0.00125	CcSEcCtD
Alprostadil—Rhinitis—Doxorubicin—sarcoma	0.000793	0.00125	CcSEcCtD
Alprostadil—Haemorrhage—Doxorubicin—sarcoma	0.000791	0.00125	CcSEcCtD
Alprostadil—Hypoaesthesia—Doxorubicin—sarcoma	0.000787	0.00124	CcSEcCtD
Alprostadil—Pharyngitis—Doxorubicin—sarcoma	0.000785	0.00124	CcSEcCtD
Alprostadil—Asthenia—Etoposide—sarcoma	0.000778	0.00123	CcSEcCtD
Alprostadil—Urethral disorder—Doxorubicin—sarcoma	0.000776	0.00122	CcSEcCtD
Alprostadil—Nausea—Mitoxantrone—sarcoma	0.000774	0.00122	CcSEcCtD
Alprostadil—Pruritus—Etoposide—sarcoma	0.000767	0.00121	CcSEcCtD
Alprostadil—Visual impairment—Doxorubicin—sarcoma	0.000762	0.0012	CcSEcCtD
Alprostadil—Erythema—Epirubicin—sarcoma	0.000744	0.00117	CcSEcCtD
Alprostadil—Diarrhoea—Etoposide—sarcoma	0.000741	0.00117	CcSEcCtD
Alprostadil—Flushing—Doxorubicin—sarcoma	0.000734	0.00116	CcSEcCtD
Alprostadil—Nervousness—Epirubicin—sarcoma	0.000723	0.00114	CcSEcCtD
Alprostadil—Back pain—Epirubicin—sarcoma	0.00072	0.00114	CcSEcCtD
Alprostadil—Dizziness—Etoposide—sarcoma	0.000717	0.00113	CcSEcCtD
Alprostadil—Muscle spasms—Epirubicin—sarcoma	0.000716	0.00113	CcSEcCtD
Alprostadil—Erythema—Doxorubicin—sarcoma	0.000689	0.00109	CcSEcCtD
Alprostadil—Anaemia—Epirubicin—sarcoma	0.000688	0.00109	CcSEcCtD
Alprostadil—Rash—Etoposide—sarcoma	0.000683	0.00108	CcSEcCtD
Alprostadil—Dermatitis—Etoposide—sarcoma	0.000683	0.00108	CcSEcCtD
Alprostadil—Headache—Etoposide—sarcoma	0.000679	0.00107	CcSEcCtD
Alprostadil—Nervousness—Doxorubicin—sarcoma	0.000669	0.00106	CcSEcCtD
Alprostadil—Syncope—Epirubicin—sarcoma	0.000667	0.00105	CcSEcCtD
Alprostadil—Back pain—Doxorubicin—sarcoma	0.000666	0.00105	CcSEcCtD
Alprostadil—Muscle spasms—Doxorubicin—sarcoma	0.000662	0.00104	CcSEcCtD
Alprostadil—Loss of consciousness—Epirubicin—sarcoma	0.000654	0.00103	CcSEcCtD
Alprostadil—Cough—Epirubicin—sarcoma	0.000649	0.00102	CcSEcCtD
Alprostadil—Convulsion—Epirubicin—sarcoma	0.000645	0.00102	CcSEcCtD
Alprostadil—Nausea—Etoposide—sarcoma	0.000644	0.00102	CcSEcCtD
Alprostadil—Hypertension—Epirubicin—sarcoma	0.000643	0.00101	CcSEcCtD
Alprostadil—Anaemia—Doxorubicin—sarcoma	0.000637	0.001	CcSEcCtD
Alprostadil—Discomfort—Epirubicin—sarcoma	0.000626	0.000988	CcSEcCtD
Alprostadil—Dry mouth—Epirubicin—sarcoma	0.00062	0.000978	CcSEcCtD
Alprostadil—Syncope—Doxorubicin—sarcoma	0.000618	0.000975	CcSEcCtD
Alprostadil—Oedema—Epirubicin—sarcoma	0.000607	0.000959	CcSEcCtD
Alprostadil—Loss of consciousness—Doxorubicin—sarcoma	0.000605	0.000955	CcSEcCtD
Alprostadil—Infection—Epirubicin—sarcoma	0.000603	0.000952	CcSEcCtD
Alprostadil—Cough—Doxorubicin—sarcoma	0.000601	0.000948	CcSEcCtD
Alprostadil—Shock—Epirubicin—sarcoma	0.000598	0.000943	CcSEcCtD
Alprostadil—Convulsion—Doxorubicin—sarcoma	0.000597	0.000942	CcSEcCtD
Alprostadil—Thrombocytopenia—Epirubicin—sarcoma	0.000595	0.000939	CcSEcCtD
Alprostadil—Hypertension—Doxorubicin—sarcoma	0.000595	0.000938	CcSEcCtD
Alprostadil—Tachycardia—Epirubicin—sarcoma	0.000593	0.000936	CcSEcCtD
Alprostadil—Skin disorder—Epirubicin—sarcoma	0.00059	0.000931	CcSEcCtD
Alprostadil—Hyperhidrosis—Epirubicin—sarcoma	0.000587	0.000927	CcSEcCtD
Alprostadil—Discomfort—Doxorubicin—sarcoma	0.000579	0.000914	CcSEcCtD
Alprostadil—Dry mouth—Doxorubicin—sarcoma	0.000573	0.000905	CcSEcCtD
Alprostadil—Hypotension—Epirubicin—sarcoma	0.000568	0.000896	CcSEcCtD
Alprostadil—Oedema—Doxorubicin—sarcoma	0.000562	0.000887	CcSEcCtD
Alprostadil—Infection—Doxorubicin—sarcoma	0.000558	0.000881	CcSEcCtD
Alprostadil—Shock—Doxorubicin—sarcoma	0.000553	0.000873	CcSEcCtD
Alprostadil—Thrombocytopenia—Doxorubicin—sarcoma	0.00055	0.000868	CcSEcCtD
Alprostadil—Tachycardia—Doxorubicin—sarcoma	0.000549	0.000866	CcSEcCtD
Alprostadil—Skin disorder—Doxorubicin—sarcoma	0.000546	0.000862	CcSEcCtD
Alprostadil—Hyperhidrosis—Doxorubicin—sarcoma	0.000543	0.000857	CcSEcCtD
Alprostadil—Dyspepsia—Epirubicin—sarcoma	0.000535	0.000844	CcSEcCtD
Alprostadil—Hypotension—Doxorubicin—sarcoma	0.000525	0.000829	CcSEcCtD
Alprostadil—Pain—Epirubicin—sarcoma	0.000519	0.00082	CcSEcCtD
Alprostadil—Feeling abnormal—Epirubicin—sarcoma	0.000501	0.00079	CcSEcCtD
Alprostadil—Dyspepsia—Doxorubicin—sarcoma	0.000495	0.000781	CcSEcCtD
Alprostadil—Pain—Doxorubicin—sarcoma	0.000481	0.000758	CcSEcCtD
Alprostadil—Abdominal pain—Epirubicin—sarcoma	0.00048	0.000758	CcSEcCtD
Alprostadil—Body temperature increased—Epirubicin—sarcoma	0.00048	0.000758	CcSEcCtD
Alprostadil—Feeling abnormal—Doxorubicin—sarcoma	0.000463	0.000731	CcSEcCtD
Alprostadil—Abdominal pain—Doxorubicin—sarcoma	0.000444	0.000701	CcSEcCtD
Alprostadil—Body temperature increased—Doxorubicin—sarcoma	0.000444	0.000701	CcSEcCtD
Alprostadil—Asthenia—Epirubicin—sarcoma	0.000436	0.000688	CcSEcCtD
Alprostadil—Pruritus—Epirubicin—sarcoma	0.00043	0.000678	CcSEcCtD
Alprostadil—Diarrhoea—Epirubicin—sarcoma	0.000416	0.000656	CcSEcCtD
Alprostadil—Asthenia—Doxorubicin—sarcoma	0.000403	0.000636	CcSEcCtD
Alprostadil—Dizziness—Epirubicin—sarcoma	0.000402	0.000634	CcSEcCtD
Alprostadil—Pruritus—Doxorubicin—sarcoma	0.000398	0.000628	CcSEcCtD
Alprostadil—Diarrhoea—Doxorubicin—sarcoma	0.000385	0.000607	CcSEcCtD
Alprostadil—Rash—Epirubicin—sarcoma	0.000383	0.000604	CcSEcCtD
Alprostadil—Dermatitis—Epirubicin—sarcoma	0.000383	0.000604	CcSEcCtD
Alprostadil—Headache—Epirubicin—sarcoma	0.000381	0.000601	CcSEcCtD
Alprostadil—Dizziness—Doxorubicin—sarcoma	0.000372	0.000587	CcSEcCtD
Alprostadil—Nausea—Epirubicin—sarcoma	0.000361	0.000569	CcSEcCtD
Alprostadil—Rash—Doxorubicin—sarcoma	0.000354	0.000559	CcSEcCtD
Alprostadil—Dermatitis—Doxorubicin—sarcoma	0.000354	0.000559	CcSEcCtD
Alprostadil—Headache—Doxorubicin—sarcoma	0.000352	0.000556	CcSEcCtD
Alprostadil—Nausea—Doxorubicin—sarcoma	0.000334	0.000527	CcSEcCtD
